Quantcast

Latest Motor neuron disease Stories

2011-07-25 23:27:04

Spinal muscular atrophy (SMA) is the most frequently inherited cause of infant mortality. Two independent research groups "” one led by Alex MacKenzie, at Children's Hospital of Eastern Ontario Research Institute, Ottawa; and one led by Umrao R. Monani, at Columbia University Medical Center, New York, and Cathleen M. Lutz, at The Jackson Laboratory, Bar Harbor "” have now generated new data in mouse models of severe SMA that provide hope that a therapeutic providing meaningful...

2011-06-29 09:07:00

NASHVILLE, Tenn., June 29, 2011 /PRNewswire-USNewswire/ -- The Olive Branch Fund: A Thisbe and Noah Scott Legacy, an organization dedicated to combating pediatric motor neuron diseases, today announced its first funding award to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University. The award will support Dr. Eggan's ongoing research investigating the neuromuscular system and the diseases that affect it. Dr. Eggan is a leading researcher in...

2011-06-23 08:00:00

ANN ARBOR, Mich., June 23, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that it has expanded its pipeline of proprietary zinc-based therapies to include a planned Phase IIb clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease. Preparations are underway to evaluate the safety and efficacy of the Company's...

2011-06-21 21:36:57

An international team of scientists led by researchers at the University of California, San Diego School of Medicine have used induced pluripotent stem cells (iPSCs) derived from patients with amyotrophic lateral sclerosis (ALS) to reveal for the first time how reduced levels of a specific protein may play a central role in causing at least one inherited form of the disease. The work, published in the June 2011 online issue of the journal Human Molecular Genetics, could help scientists...

2011-06-11 00:00:29

The ALS Association Rocky Mountain Chapter is proud to announce that Chuck La Rue, aka "Chuck Walking", will take the final steps in his 3,000+ mile walk across the country at the Santa Monica Pier on Sunday, June 12. Santa Monica, CA (PRWEB) June 10, 2011 The ALS Association Rocky Mountain Chapter is proud to announce that Chuck La Rue, aka "Chuck Walking", will take the final steps in his 3,000+ mile walk across the country at the Santa Monica Pier on Sunday, June 12. Chuck started his...

2011-06-07 07:00:00

Augie Nieto, ALS Patient and Fitness Pioneer also to be Recognized CAMBRIDGE, Mass., June 7, 2011 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today that it will present Congressman Michael Capuano (D-MA) with its first ever "Lou Gehrig Award" during its annual A White Coat Affair gala event this November 3rd. The award recognizes the Congressman for his tireless efforts in Congress to advocate for additional funding for research leading to an...

2011-06-06 14:00:00

Failure in nerve-fiber navigation corrected in zebrafish model; suggests possibility of a drug treatment BOSTON, June 6, 2011 /PRNewswire-USNewswire/ -- Spinal muscular atrophy (SMA) is the leading genetic cause of death in children under 2, with no treatment other than supportive care. In the Proceedings of the National Academy of Sciences (Early Edition, week of June 6), researchers at Children's Hospital Boston show how loss or mutation of the SMA gene causes progressive muscle...

2011-06-06 07:00:00

CAMBRIDGE, Mass., June 6, 2011 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) announced today the agenda for its 7th annual Leadership Summit to be held in Cambridge on November 4th, 2011. This year's Leadership Panel will feature: Christopher Austin, Ph.D., scientific director of the National Institutes of Health Center for Translational Therapeutics; Robert Blum, CEO of Cytokinetics, Inc.; Hon. Jim Greenwood, president and CEO of the Biotechnology Industry...

2011-06-06 08:00:00

WOONSOCKET, R.I., June 6, 2011 /PRNewswire/ -- On June 5, CVS/pharmacy kicked-off its 10th annual in-store fundraising campaign -- "Researching a Cure" -- to support the fight against amyotrophic lateral sclerosis (ALS). Funds raised through the campaign benefit the ALS Therapy Alliance (ATA), a leading organization dedicated to advancing ALS research. Through the Researching a Cure campaign, CVS/pharmacy has raised more than $23 million in its stores and online at www.cvs.com, to fund new...

2011-05-19 07:37:00

First ever clinical trial approved for SMA with a novel drug specifically designed to treat the disease CHICAGO, May 19, 2011 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the U.S. Food and Drug Administration to commence a Phase I safety study in healthy volunteers for RG3039, formerly called Quinazoline495, which is being developed for Spinal Muscular Atrophy. FSMA began the Quinazoline program in...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related